SKRININIG FITOKIMIA ASHITABA (Angelica keskei) TERHADAP ENOIL ACP REDUKTASE (inhA) Mycobacterium tuberculosis SEBAGAI SENYAWA POTENSIAL ANTI-TB

نویسندگان

چکیده

Tuberkulosis (TB) merupakan penyakit menular yang telah menginfeksi seperempat populasi dunia. Isoniazid adalah obat pilihan pertama untuk mengobati TB dengan mekanisme menghambat enoil ACP reductase (inhA) berperan penting dalam sintesis dinding sel M. tuberculosis. Akan tetapi, penggunaan isoniazid jangka relatif panjang dapat menghasilkan efek hepatotoksik sehingga diperlukan pengembangan anti-TB baru. Ekstrak ashitaba dilaporkan memiliki aktivitas anti-TB. Oleh karena itu, penelitiaan ini dilakukan menemukan senyawa aktif bertanggung jawab terhadap secara in siliko reseptor inhA. Metode penambatan molekul menggunakan perangkat lunak Autodock tools 1.5.6. Hasil menunjukkan dari 40 fitokimia diuji, terdapat 8 nilai energi ikatan bebas dan konstanta inhibisi lebih baik ligan alami aktif, yaitu iakatan kecil aktif. Senyawa prostratol F xantoangelol I 2 terbaik interaksi mirip potensial dikembangkan menjadi

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The ethanolic extract of ashitaba stem (Angelica keskei [Miq.] Koidz) as future antituberculosis

Considering the easy contagion of tuberculosis (TB) disease spread and the emergence of multidrug-resistant TB, which directly impacts the failure of therapeutic goals and mortality rates increasing, TB disease control remains to be the main concern of continuous health development effort. Therefore, the discovery of new TB drug is needed. This research assessed the new natural anti-TB drug fro...

متن کامل

A slow, tight-binding inhibitor of InhA, the enoyl-ACP reductase from Mycobacterium tuberculosis

InhA, the enoyl-ACP reductase in Mycobacterium tuberculosis is an attractive target for the development of novel drugs against tuberculosis, a disease that kills more than two million people each year. InhA is the target of the current first line drug isoniazid (INH) for the treatment of tuberculosis infections. Compounds that directly target InhA and do not require activation by the mycobacter...

متن کامل

Antioxidant properties of flavonoids

Flavonoids, metabolit sekunder terbanyak yang bersumber dari tanaman, telah lama dimanfaatkan sebagai obat tradisional dan secara ilmiah juga telah terbukti memiliki efek farmakologi. Senyawa ini juga memiliki beragam manfaat terhadap kesehatan sehingga sangat berpotensi sebagai bahan baku untuk pengembangan obat baru. Penelitian terbaru memaparkan pemanfaatan flavonoids sebagai antioksidan unt...

متن کامل

A Structural and Energetic Model for the Slow-Onset Inhibition of the Mycobacterium tuberculosis Enoyl-ACP Reductase InhA

Slow-onset enzyme inhibitors are of great interest for drug discovery programs since the slow dissociation of the inhibitor from the drug-target complex results in sustained target occupancy leading to improved pharmacodynamics. However, the structural basis for slow-onset inhibition is often not fully understood, hindering the development of structure-kinetic relationships and the rational opt...

متن کامل

TB or not TB? Mycobacterium celatum mimicking Mycobacterium tuberculosis: A case of mistaken identity

Mycobacterium celatum is a slow-growing, non-tuberculous mycobacterium (NTM) and a rare cause of infection in humans. Infection occurs primarily by inhalation or direct inoculation from environmental sources, and this pathogen has been reported to cause localized infections in the lungs and lymph nodes of both immunocompetent and immunocompromised patients, and disseminated disease in immunocom...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Indonesia natural research pharmaceutical journal

سال: 2022

ISSN: ['2502-8421']

DOI: https://doi.org/10.52447/inrpj.v7i1.5481